Evidence-Based Cardiology Book

	Contributors	xi
	Preface to the Second edition	xvii
	Preface to the First edition	xix
	Glossary	xxi
Part I	General concepts and critical appraisal	1
1	What is evidence-based cardiology?	3
2	A critical appraisal of the cardiovascular history and physical examination	14
3	Obtaining incremental information from diagnostic tests	23
4	Clinical trials and meta-analysis	34
5	Finding current best evidence to practice evidence-based cardiology	40
6	Understanding concepts related to health economics	46
7	Introduction to decision analysis	56
8	Assessing and changing cardiovascular clinical practices	71
Part II	Prevention of cardiovascular diseases	89
9	Global perspective on cardiovascular disease	91
10	Tobacco: global burden and community solutions	103
11	Tobacco and cardiovascular disease: achieving smoking cessation	114
12	Lipids and cardiovascular disease	121
13	Use of lipid lowering agents in the prevention of cardiovascular disease	130
14	Blood pressure and cardiovascular disease	146
15	Glucose abnormalities and cardiovascular disease: "dysglycemia" as an emerging cardiovascular risk factor	161
16	Physical activity and exercise in cardiovascular disease prevention and rehabilitation	170
17	Psychosocial factors in the primary and secondary prevention of coronary heart disease: an updated systematic review of prospective cohort studies	181
18	Emerging approaches in cardiovascular prevention	219
19	Obesity	231
20	Postmenopausal hormone therapy and cardiovascular disease	244
21	Ethnicity and cardiovascular disease	259
22	The fetal origins of coronary heart disease	279
23	Molecular genetics of cardiovascular disorders	287
24	Cost effectiveness of prevention of cardiovascular disease	300
25	Diet and cardiovascular disease	309
Part IIIa	Specific cardiovascular disorders: Stable coronary artery disease	327
26	Anti-ischemic drugs	329
27	Impact of revascularization procedures in chronic coronary artery disease on clinical outcomes: a critical review of the evidence	339
28	Adjunctive medical therapy in percutaneous coronary intervention	360
29	Restenosis: etiologies and prevention	371
Part IIIb	Specific cardiovascular disorders: Acute ischemic syndromes and acute myocardial infarction	395
30	Acute non-ST-segment elevation coronary syndromes: unstable angina and non-ST-segment elevation myocardial infarction	397
31	Fibrinolytic therapy	426
32	Mechanical reperfusion strategies in patients presenting with acute myocardial infarction	444
33	Adjunctive antithrombotic therapy for ST-elevation acute myocardial infarction	456
34	Pain relief, general management, and other adjunctive treatments	477
35	Complications after myocardial infarction	488
36	An integrated approach to the management of patients after the early phase of the acute coronary syndromes	507
Part IIIc	Specific cardiovascular disorders: Atrial fibrillation and supraventricular tachycardia	517
37	Atrial fibrillation: antiarrhythmic therapy	519
38	Atrial fibrillation: antithrombotic therapy	548
39	Atrial fibrillation: non-pharmacologic therapies	556
40	Supraventricular tachycardia: drugs v ablation	567
Part IIId	Specific cardiovascular disorders: Ventricular arrhythmias, bradyarrhythmias and cardiac arrest	575
41	Prevention and treatment of life-threatening ventricular arrhythmia and sudden death	577
42	Impact of pacemakers: when and what kind?	587
43	Syncope	619
44	Cardiopulmonary resuscitation	634
Part IIIe	Specific cardiovascular disorders: Left ventricular dysfunction	641
45	Prevention of congestive heart failure and treatment of asymptomatic left ventricular dysfunction	643
46	Management of overt heart failure	659
47	Acute myocarditis and dilated cardiomyopathy	681
48	Hypertrophic cardiomyopathy	703
49	Other cardiomyopathies	718
Part IIIf	Specific cardiovascular disorders: Pericardial disease	733
50	Pericardial disease: an evidence-based approach to diagnosis and treatment	735
Part IIIg	Specific cardiovascular disorders: Valvular heart disease	749
51	Rheumatic heart disease: prevention and acute treatment	751
52	Mitral valve disease: indications for surgery	758
53	Indications for surgery in aortic valve disease	767
54	Balloon valvuloplasty: aortic valve	782
55	Balloon valvuloplasty: mitral valve	796
56	Valve repair and choice of valves	809
57	Diagnosis and management of infective endocarditis	817
58	Antithrombotic therapy after heart valve replacement	832
Part IIIh	Specific cardiovascular disorders: Other conditions	837
59	Treatment of patients with stroke	839
60	Heart disease and pregnancy	853
61	Venous thromboembolic disease	864
62	Peripheral vascular disease	877
Part IV	Clinical applications	887
63	Clinical applications of external evidence	889
64	Stable angina: choice of PCI v CABG v drugs	892
65	Acute coronary syndromes	896
66	Acute myocardial infarction	902
67	Postmyocardial infarction: preventive measures	906
68	Metabolic risk and secondary prevention of coronary disease	909
69	Peripheral vascular disease with suspect coronary artery disease	912
70	Heart failure	915
71	Atrial fibrillation	921
72	Ventricular dysrhythmias: pharmacologic v non-pharmacologic treatment	925
73	Bradyarrhythmias: choice of pacemaker	931
74	Valvular heart disease: timing of surgery	934
	Index	939